Africa

  • Algeria
  • South Africa and Sub-Saharan Africa
  • Tunisia

Asia Pacific

  • Australia
  • China
  • Hong Kong
  • Japan
  • Korea
  • Malaysia
  • New Zealand
  • Singapore
  • Taiwan

Europe

  • Italy
  • Switzerland
    • Switzerland DE
    • Switzerland FR
    • Switzerland IT
  • Austria
  • Belgium & Luxembourg
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Norway
  • Spain
  • Sweden
  • Turkey
  • United Kingdom
  • Portugal
  • Netherlands

Middle East

  • Israel
    • Israel HE
    • Israel EN
  • Kuwait
  • Saudi Arabia
  • UAE

North America

  • Canada
    • Canada EN
    • Canada FR

Latin America / Caribbean

  • Mexico
  • Puerto Rico

South America

  • Argentina
    • Argentina ES
    • Argentina FR
  • Brazil
  • Chile
  • Colombia
  • Uruguay

test

AbbViePro Logo 2023
MENU
  • Home
  • Products
  • Therapy Area
    • Immunology

      • Rheumatology
      • Dermatology
      • Gastroenterology
    • Oncology

      • Blood Cancers
      • Solid Tumours
    • Neuroscience

      • Neurology
    • Virology

      • Hepatitis C (HCV)
    • Eye Care

      • Opthalmology
      • ACUITI
  • Events & Training
    • Trainings

  • Contact & Services
Log in
or
Register
Log in
or
Register
  • Home
  • Products
  • Therapy Area
    • Immunology

      • Rheumatology
      • Dermatology
      • Gastroenterology
    • Oncology

      • Blood Cancers
      • Solid Tumours
    • Neuroscience

      • Neurology
    • Virology

      • Hepatitis C (HCV)
    • Eye Care

      • Opthalmology
      • ACUITI
  • Events & Training
    • Trainings

  • Contact & Services

Your recommended articles

Take a look at these articles that may be of interest to you.

image
Skyrizi PS
{{getHighlightedArticleDate('05 Aug 2022')}}

Neue Daten: Biologika

Open Title : Article b Neue Daten: Biologika-Therapie bei Psoriasis unter realen Bedingungen aus Sicht der Patient*innen...

In publishing and graphic design, Lorem ipsum is a placeholder text commonly used to demonstrate the visual form of a document or a typeface without relying on meaningful content. Lorem ipsum may be u...

image
Rinvoq RA
{{getHighlightedArticleDate('04 Aug 2022')}}

Neue Daten: Biologika

Open Title : Article a Neue Daten: Biologika-Therapie bei Psoriasis unter realen Bedingungen aus Sicht der Patient*innen...

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam pellentesque, arcu ac ullamcorper rhoncus, metus ex vulputate odio, id feugiat magna urna sed enim. Maecenas maximus lorem sit ameten.L...

Previous
Next

Filter events

Applied Filter

None applied. Select an item from the dropdowns above to filter the below events.
{{filterItem.name}}

and/or filter by topic:

{{topic.name}}

Sorry, we couldn’t find any articles that match your chosen filters.

Reset filter to see all of our available articles.

{{articleItem.title}}
Topic tag
{{typeTag.name}}
{{articleItem.date}}

{{articleItem.upperCaption}}

{{articleItem.buttonText}}
img
img
Our therapy areas
Immunology
Oncology
Neurology
Virology
Our therapy areas
Immunology
Oncology
Neurology
Virology
Additional info
Privacy Policy
Terms and Conditions
Manage Cookies
Contact Us
Additional info
Privacy Policy
Terms and Conditions
Manage Cookies
Contact Us
This website is intended for Healthcare Professionals

Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.

This website is intended for Italy Healthcare Professionals

Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.

Date of Preparation: December 2018  |   Approval code AT-ABBV-210058 Aug 21    |    Copyright © 2018 AbbVie Inc. North Chicago, Illinois, U.S.A.

Date of Preparation: December 2018 

Approval code AT-ABBV-210058 Aug 21

Copyright © 2018 AbbVie Inc. North Chicago, Illinois, U.S.A.

Leaving Site

You are now leaving the AbbVie Pro Portal and being re-directed to an external website. The information you are about to be referred to may not comply with the regulatory requirements.

Do you wish to continue?

No
Yes
  • www-q.abbviepro.com
  • www-d.abbviepro.com
  • preview.abbviepro.com
  • www.abbviepro.com
  • www-pro.abbvieinc.brainstationdelivery.com
  • stories.abbvie.com
  • gmm2020.abbviepro.com
  • www.abbvie.com
  • www.ema.europa.eu
  • training-preview.abbviepro.com
  • training.abbviepro.com
  • training-d.abbviepro.com
  • training-q.abbviepro.com
  • https://id.abbvie.com/Login?

result found for {{key}}

  • {{result.pageTitle}}
    {{result.specialization}}

result found for {{key}}

  • {{result.pageTitle}}
    {{result.specialization}}

nothing is available for {{key}}